Abstract
The regimens for factor Xa (FXa) inhibitors (apixaban, edoxaban, and rivaroxaban) vary with venous thromboembolism (VTE) or non-valvular atrial fibril......
小提示:本篇文献需要登录阅读全文,点击跳转登录